Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis
Yue Ding, Yi‐Lin Yan, Yihui Dong, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108512-108512
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Targeting purine metabolism in ovarian cancer
Jingchun Liu, Shasha Hong, Yang Jiang, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 50
Fantastic voyage: The journey of NLRP3 inflammasome activation
Xiangyong Que, Sihao Zheng, Qibin Song, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 819-829
Open Access | Times Cited: 27
GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer
Qin Liu, Yabing Sun, Tao Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy
Moon Nyeo Park, Jinwon Choi, Md. Maharub Hossain Fahim, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
NLRP3 inflammasome in hepatic diseases: A pharmacological target
Erika Ramos‐Tovar, Pablo Muriel
Biochemical Pharmacology (2023) Vol. 217, pp. 115861-115861
Closed Access | Times Cited: 22
Pyroptosis and inflammasomes in cancer and inflammation
Jie‐Lin Wang, Shengni Hua, Hai‐Juan Bao, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 18
The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics
Ahmed Hjazi, F. Nasir, Rabia Noor, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154616-154616
Closed Access | Times Cited: 17
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Isak W. Tengesdal, Charles A. Dinarello, Carlo Marchetti
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108545-108545
Closed Access | Times Cited: 17
High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
Yinghui Ren, Yongmei Qian, Qicheng Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword
Yingle Tang, Tao Yan, Lin Zhu, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110107-110107
Closed Access | Times Cited: 16
The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
Stavros P. Papadakos, Nikolaos Dedes, Elias Kouroumalis, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3150-3150
Open Access | Times Cited: 19
Role of NLRP3 inflammasome in systemic sclerosis
Cong Lin, Zhixing Jiang, Ling Cao, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 19
NLRP3 inflammasome in digestive diseases: From mechanism to therapy
Rui Qiang, Yanbo Li, Xin-can Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Unmasking the NLRP3 inflammasome in dendritic cells as a potential therapeutic target for autoimmunity, cancer, and infectious conditions
Shiva Alipour, Amirhossein Mardi, Neda Shajari, et al.
Life Sciences (2024) Vol. 348, pp. 122686-122686
Closed Access | Times Cited: 4
Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome
Nazanin Pazhouhesh Far, Mahsa Hajiheidari Varnousafaderani, Ferdos Faghihkhorasani, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 4
Targeting purine metabolism-related enzymes for therapeutic intervention: A review from molecular mechanism to therapeutic breakthrough
Di Wu, Shengqiang Yang, Chenyang Yuan, et al.
International Journal of Biological Macromolecules (2024), pp. 136828-136828
Closed Access | Times Cited: 4
Nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 inflammasome: From action mechanism to therapeutic target in clinical trials
Chunye Zhang, Shuai Liu, Yuxiang Sui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy
Hamza Abu Owida, Ahmed Abed, Farag M. A. Altalbawy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Mitochondrial dysfunction in AMI: mechanisms and therapeutic perspectives
Jingle Shi, Yiding Yu, Huajing Yuan, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Interplay between inflammasomes and PD-1/PD-L1 and their implications in cancer immunotherapy
Z.M. Jiao, Jun Zhang
Carcinogenesis (2023) Vol. 44, Iss. 12, pp. 795-808
Closed Access | Times Cited: 9
Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy
Lingrui Li, Lei Chen, Zhi‐Jun Sun
Life Sciences (2024) Vol. 354, pp. 122951-122951
Closed Access | Times Cited: 3
NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma
Lei Chen, Shu‐Cheng Wan, Liang Mao, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 6, pp. 1647-1660
Open Access | Times Cited: 14
Impact of NLRP3 gene polymorphisms (rs10754558 and rs10733113) on HPV infection and cervical cancer in southern Chinese population
Qingchun Lu, Xiaoxia Lao, Jinghua Gan, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
Yongwei Chen, Yanyun Zhu, Yuanmei Dong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients
Sawsan Elgohary, Reda A. Eissa, H.M. El Tayebi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14254-14254
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top